# ILLUMINA, INC. (ILMN) — capital_raise/public_offering [announced]
Source: sec.gov · situation sit_98e445e9a33badfa8eb1 · public 9801316357180909688 · retrieved 2026-08-20T13:19:52.166Z

## Overview
Illumina, Inc. is a laboratory analytical instruments company engaged in genomic sequencing and analysis.

On August 13, 2026, Illumina, Inc. entered into a new credit agreement providing for a $1,000 million senior unsecured five-year revolving credit facility with Bank of America, N.A. as administrative agent, issuing bank and swingline lender, along with other issuing banks. The facility includes a $50 million sublimit for swingline borrowings and a $75 million sublimit for letters of credit. Loans bear interest at a variable rate based on either Term SOFR or the alternate base rate, plus an applicable rate that varies with the Company's debt rating. The facility matures on August 13, 2031, subject to three one-year extensions at the Company's option with lender consent. The new credit agreement replaces and terminates the prior credit agreement dated January 4, 2023.

## Terms
- Counterparty: Bank of America, N.A. and other lenders · Deal value: $1.00B

## Key dates
- Announced 2026-08-13 · Expiry 2031-08-13

## Timeline
- 2026-08-13 · 8-K (0000950157-26-000888): 8-K - ILLUMINA, INC. — *Illumina, Inc. is a laboratory analytical instruments company engaged in genomic sequencing and analysis.* On August 13, 2026, Illumina, Inc. entered into a new credit agreement providing for a $1,000 million senior unsecured five-year revolving credit facility with Bank of America, N.A. as administrative agent, issuing bank and swingline lender, along with other issuing banks. The facility includes a $50 million sublimit for swingline borrowings and a $75 million sublimit for letters of credit. Loans bear interest at a variable rate based on either Term SOFR or the alternate base rate, plus an applicable rate that varies with the Company's debt rating. The facility matures on August 13, 2031, subject to three one-year extensions at the Company's option with lender consent. The new credit agreement replaces and terminates the prior credit agreement dated January 4, 2023.
  https://www.sec.gov/Archives/edgar/data/1110803/0000950157-26-000888.txt

## Citations
- 0000950157-26-000888 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000095015726000888